Neurocheck Frequency for Brain Aneurysm Patients' Sleep Quality
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the frequency of neurological exams, known as "Neurocheck frequency," affects sleep quality for ICU patients after an elective aneurysm coiling procedure. Researchers will compare two groups: one group will undergo exams every hour, while the other will have exams every two hours. They seek to discover if fewer interruptions enhance sleep and overall recovery. Patients who have undergone a straightforward elective procedure for an unruptured brain aneurysm and do not have sleep disorders or cognitive issues may be suitable candidates. As an unphased trial, this study allows patients to contribute to research that could improve ICU care practices and enhance recovery experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this neurocheck frequency protocol is safe for brain aneurysm patients?
Research shows that regular brain checks, known as neurochecks, are common for patients with brain injuries. These checks help detect any worsening of the condition. However, studies indicate that hourly checks might disturb sleep and cause issues like confusion. This is important because sleep is vital for healing.
Less information exists about conducting neurochecks every two hours. Some studies suggest that less frequent checks might improve sleep without missing important changes in the patient's condition.
In summary, both checking schedules aim to keep patients safe, but hourly checks might disrupt sleep. Current research seeks to determine which schedule better balances sleep and patient safety.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the frequency of neurochecks impacts the sleep quality of brain aneurysm patients. Unlike standard care that often involves frequent disruptions for neurological exams, this trial examines the effects of reducing these interruptions by comparing hourly checks with every-other-hour checks. The hope is to find a balance that maintains patient safety while allowing for better rest, which could significantly improve recovery and quality of life for patients.
What evidence suggests that neurocheck frequency is effective for improving sleep quality in brain aneurysm patients?
This trial will compare two neurocheck frequencies for brain aneurysm patients: hourly and every-other-hour checks. Studies have shown that regular neurochecks are important after an injury. However, frequent checks can disrupt sleep quality. Research indicates that hourly checks might disturb sleep more than checks every two hours. Some studies suggest that checking every two hours can still effectively monitor patients while allowing for better sleep. Both methods aim to detect changes in brain health, but balancing monitoring with the need for rest is crucial. The goal is to find a schedule that keeps patients safe while maximizing their sleep.12346
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had a successful elective coiling procedure for an unruptured brain aneurysm and are in the ICU. It's not for those with past brain injuries, sleep disorders, cognitive issues, ongoing sedation, mechanical ventilation, pregnancy, or communication barriers in English.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Monitoring
Patients are monitored every 15-30 minutes for up to 6 hours post-procedure
Randomized Neurochecks
Patients undergo Q1 or Q2 neurochecks with EEG monitoring for at least 8 hours overnight
Follow-up
Participants are monitored for sleep characteristics and complete the Richards-Campbell Sleep Questionnaire
What Are the Treatments Tested in This Trial?
Interventions
- Neurocheck frequency
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
National Institute on Aging (NIA)
Collaborator